Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin - A Double-blind, Randomized, Placebo-controlled, Cross-over Study

NCT04659915 is registered in ClinicalTrials.gov with Eleonora Seelig as lead sponsor.

NCT NCT04659915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin - A Double-blind, Randomized, Placebo-controlled, Cross-over Study
Lead sponsor
Eleonora Seelig
Phase
Phase 4
Overall status
Completed
Start date
February 25, 2021
Completion date
August 18, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucocorticoid effect